In this study, we used the p53 and pRb negative bladder cancer cell line 5637 to provide evidence that mdm2 interacts with the hTR core promoter in vivo (figure 1) and serves as a negative regulator of the hTR gene promoter in vitro (figure 2). This evidence concerns the gene TP53 and urinary bladder cancer.